Interferon epsilon as a novel anti-viral agent in the testis
RNA-seq (gene expression) · mouse · 61 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 61 samples: 19 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Interferon epsilon is produced in the testis and protects the male reproductive tract against virus infection, inflammation and damagePLoS pathogens · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE253518_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1065943 and SRA study SRP483171. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 54 samples.
How we read this: 19 replicated groups read from 61 sample titles; they account for 54 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8012069 Human Sertoli cells, therapeutic buffer treatment, 24h, MOI 10, replicate 1 Human Sertoli cells, th…
- GSM8012070 Human Sertoli cells, therapeutic buffer treatment, 24h, MOI 10, replicate 2 Human Sertoli cells, th…
- GSM8012071 Human Sertoli cells, therapeutic buffer treatment, 24h, MOI 10, replicate 3 Human Sertoli cells, th…
- GSM8012072 Human Sertoli cells, therapeutic buffer treatment, 24h, MOI 5, replicate 1 Human Sertoli cells, th…
- GSM8012073 Human Sertoli cells, therapeutic buffer treatment, 24h, MOI 5, replicate 2 Human Sertoli cells, th…
- GSM8012074 Human Sertoli cells, therapeutic buffer treatment, 24h, MOI 5, replicate 3 Human Sertoli cells, th…
- GSM8012075 Human Sertoli cells, therapeutic IFNε treatment, 24h, MOI 10, replicate 1 Human Sertoli cells, th…
- GSM8012076 Human Sertoli cells, therapeutic IFNε treatment, 24h, MOI 10, replicate 2 Human Sertoli cells, th…
- GSM8012077 Human Sertoli cells, therapeutic IFNε treatment, 24h, MOI 10, replicate 3 Human Sertoli cells, th…
- GSM8012078 Human Sertoli cells, therapeutic IFNε treatment, 24h, MOI 5, replicate 1 Human Sertoli cells, th…
- GSM8012079 Human Sertoli cells, therapeutic IFNε treatment, 24h, MOI 5, replicate 2 Human Sertoli cells, th…
- GSM8012080 Human Sertoli cells, therapeutic IFNε treatment, 24h, MOI 5, replicate 3 Human Sertoli cells, th…
- GSM8012081 Human Sertoli cells, prophylactic buffer treatment, 24h, MOI 10, replicate 1 Human Sertoli cells, pr…
- GSM8012082 Human Sertoli cells, prophylactic buffer treatment, 24h, MOI 10, replicate 2 Human Sertoli cells, pr…
- GSM8012083 Human Sertoli cells, prophylactic buffer treatment, 24h, MOI 10, replicate 3 Human Sertoli cells, pr…
- GSM8012084 Human Sertoli cells, prophylactic buffer treatment, 24h, MOI 5, replicate 1 Human Sertoli cells, pr…
- GSM8012085 Human Sertoli cells, prophylactic buffer treatment, 24h, MOI 5, replicate 2 Human Sertoli cells, pr…
- GSM8012086 Human Sertoli cells, prophylactic buffer treatment, 24h, MOI 5, replicate 3 Human Sertoli cells, pr…
- GSM8012087 Human Sertoli cells, prophylactic IFNε treatment, 24h, MOI 10, replicate 1 Human Sertoli cells, pr…
- GSM8012088 Human Sertoli cells, prophylactic IFNε treatment, 24h, MOI 10, replicate 2 Human Sertoli cells, pr…
- GSM8012089 Human Sertoli cells, prophylactic IFNε treatment, 24h, MOI 10, replicate 3 Human Sertoli cells, pr…
- GSM8012090 Human Sertoli cells, prophylactic IFNε treatment, 24h, MOI 5, replicate 1 Human Sertoli cells, pr…
- GSM8012091 Human Sertoli cells, prophylactic IFNε treatment, 24h, MOI 5, replicate 2 Human Sertoli cells, pr…
- GSM8012092 Human Sertoli cells, prophylactic IFNε treatment, 24h, MOI 5, replicate 3 Human Sertoli cells, pr…
- GSM8012093 Human Sertoli cells, therapeutic buffer treatment, 48h, MOI 10, replicate 1 Human Sertoli cells, th…
- GSM8012094 Human Sertoli cells, therapeutic buffer treatment, 48h, MOI 10, replicate 2 Human Sertoli cells, th…
- GSM8012095 Human Sertoli cells, therapeutic buffer treatment, 48h, MOI 10, replicate 3 Human Sertoli cells, th…
- GSM8012096 Human Sertoli cells, therapeutic buffer treatment, 48h, MOI 5, replicate 1 Human Sertoli cells, th…
- GSM8012097 Human Sertoli cells, therapeutic buffer treatment, 48h, MOI 5, replicate 2 Human Sertoli cells, th…
- GSM8012098 Human Sertoli cells, therapeutic buffer treatment, 48h, MOI 5, replicate 3 Human Sertoli cells, th…
- GSM8012099 Human Sertoli cells, therapeutic IFNε treatment, 48h, MOI 10, replicate 1 Human Sertoli cells, th…
- GSM8012100 Human Sertoli cells, therapeutic IFNε treatment, 48h, MOI 10, replicate 2 Human Sertoli cells, th…
- GSM8012101 Human Sertoli cells, therapeutic IFNε treatment, 48h, MOI 10, replicate 3 Human Sertoli cells, th…
- GSM8012102 Human Sertoli cells, therapeutic IFNε treatment, 48h, MOI 5, replicate 1 Human Sertoli cells, th…
- GSM8012103 Human Sertoli cells, therapeutic IFNε treatment, 48h, MOI 5, replicate 2 Human Sertoli cells, th…
- GSM8012104 Human Sertoli cells, therapeutic IFNε treatment, 48h, MOI 5, replicate 3 Human Sertoli cells, th…
- GSM8012105 Human Sertoli cells, prophylactic buffer treatment, 48h, MOI 10, replicate 1 Human Sertoli cells, pr…
- GSM8012106 Human Sertoli cells, prophylactic buffer treatment, 48h, MOI 10, replicate 2 Human Sertoli cells, pr…
- GSM8012107 Human Sertoli cells, prophylactic buffer treatment, 48h, MOI 10, replicate 3 Human Sertoli cells, pr…
- GSM8012108 Human Sertoli cells, prophylactic buffer treatment, 48h, MOI 5, replicate 1 Human Sertoli cells, pr…
+ 21 more — browse all 61 samples with per-sample file links →
- GSE269054 Spatially clustered type I interferon responses at injury borderzones 37 samples shares interferon
- GSE241209 Tissue factor binds to and inhibits interferon-α receptor-1 signaling 21 samples shares interferon
- GSE300460 TET3 Promotes Tumor Immune Evasion Through Negative Regulation of Type I Interferon Signaling [RNA-Seq] 20 samples shares interferon
- GSE247586 RIG-I sensing of self-RNA in aged endothelial cells links cellular senescence with an interferon gene signature 7 samples shares interferon
- GSE300464 TET3 Promotes Tumor Immune Evasion Through Negative Regulation of Type I Interferon Signaling 28 samples shares interferon
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.